News|Podcasts|January 9, 2024
Prioritizing R&D Initiatives to Support Cell Line Development
Author(s)AGC Biologics
Robust, scalable manufacturing of novel therapeutics requires partnering with a CDMO equipped to adapt to changes in the market and knowledgeable on the latest technologies used to support cell line development.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
4
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
5
